genetic dynamics and factors predictive of survival in relapsed aml
Published 3 months ago • 32 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:12
understanding genetic and non-genetic mechanisms involve in aml disease progression
-
1:33
updates to the icc classification of aml
-
2:17
understanding the molecular complexity of aml
-
2:34
the evolution of the aml treatment paradigm
-
5:15
impact of mmrd and eln genetic classification in outcomes for patients with aml underoging allohct
-
3:40
genetic abnormalities for detecting patients at risk of aml
-
1:42
developments in prognostic factors of acute myeloid leukemia (aml)
-
1:34
the mutational profile in patients with cll treated with acalabrutinib or ibrutinib
-
4:58
the molecular heterogeneity of acute myeloid leukemia (aml) – new data and implications
-
1:46
application of molecular genetic testing in aml
-
1:33
all diagnostics: challenges and considerations
-
2:57
genetic biomarkers of response to venetoclax in aml
-
4:17
aml: genetic screening and subtypes
-
1:26
prognostic and predictive biomarkers in cll and their potential in guiding treatment decisions
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
0:48
building genetic assessments into how we determine prognosis of all
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
3:37
the future of aml treatment
-
1:20
mimetics: the future of aml treatment?